TABLE 4.
Logistic Regression Model for Factors Predictive of Clinical Response (ever) to Vedolizumab
| Variable | Odds Ratio (CI) | P |
|---|---|---|
| Previous Anti-TNF exposure | 0.5 (0.05–4.3) | 0.50 |
| Pouchitis ≤1 year after IPAA | 0.3 (0.1–0.9) | 0.03 |
| Obesity | 3.1 (0.6–15.5) | 0.17 |
CI, confidence interval